Aurinia Pharmaceuticals's market cap is currently $1.12B. The company's EPS TTM is $-0.158; its P/E ratio is ―; Aurinia Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 175.51M	$ 134.03M	$ 45.60M	$ 50.12M	$ 318.00K
Gross Profit	$ 161.37M	$ 128.37M	$ 44.51M	$ -209.00K	$ -52.55M
Operating Income	$ -91.69M	$ -111.47M	$ -180.74M	$ -104.29M	$ -82.54M
EBITDA	$ -63.05M	$ -103.65M	$ -177.44M	$ -102.92M	$ -89.77M
Net Income	$ -78.02M	$ -108.18M	$ -180.97M	$ -102.68M	$ -123.85M
Balance Sheet
Cash & Short-Term Investments	$ 350.49M	$ 389.39M	$ 466.08M	$ 398.33M	$ 306.02M
Total Assets	$ 548.06M	$ 470.86M	$ 543.37M	$ 463.66M	$ 326.68M
Total Debt	$ 97.61M	$ 8.09M	$ 8.74M	$ 8.41M	$ 0.00
Net Debt	$ 48.73M	$ -86.08M	$ -223.16M	$ -263.94M	$ -306.02M
Total Liabilities	$ 170.11M	$ 65.42M	$ 64.28M	$ 55.91M	$ 53.17M
Stockholders' Equity	$ 377.95M	$ 405.44M	$ 479.09M	$ 407.75M	$ 273.52M
Cash Flow
Free Cash Flow	$ -34.18M	$ -79.82M	$ -159.19M	$ -77.20M	$ -63.56M
Operating Cash Flow	$ -33.46M	$ -79.53M	$ -157.69M	$ -69.86M	$ -63.46M
Investing Cash Flow	$ -6.71M	$ -60.63M	$ -103.87M	$ -158.19M	$ 7.78M
Financing Cash Flow	$ -5.13M	$ 2.43M	$ 221.11M	$ 194.38M	$ 243.73M

Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

Income Statement >

Aurinia Pharmaceuticals Debt to Assets

Balance Sheet >

Aurinia Pharmaceuticals Cash Flow

Cash Flow >

Aurinia Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing